Physician-Delegated Unobserved Induction with Buprenorphine in Pharmacies

N Engl J Med. 2023 Jan 12;388(2):185-186. doi: 10.1056/NEJMc2208055.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Buprenorphine* / therapeutic use
  • Delegation, Professional
  • Humans
  • Narcotic Antagonists* / therapeutic use
  • Opiate Substitution Treatment* / methods
  • Opioid-Related Disorders* / drug therapy
  • Patient Care / methods
  • Pharmacies*
  • Pharmacists

Substances

  • Buprenorphine
  • Narcotic Antagonists

Associated data

  • ClinicalTrials.gov/NCT04139213